The cascade radical annulation approach to new analogues of camptothecins. Combinatorial synthesis of silatecans and homosilatecans
- PMID: 11193887
- DOI: 10.1111/j.1749-6632.2000.tb07030.x
The cascade radical annulation approach to new analogues of camptothecins. Combinatorial synthesis of silatecans and homosilatecans
Abstract
An overview of the cascade radical annulation approach to the camptothecin family of antitumor drugs is presented. This combinatorial synthetic approach involves two key steps: (1) N-propargylation of a lactone/pyridone D/E ring fragment and (2) cascade radical annulation of an A-ring isonitrile to form rings B and C. The synthesis is probably the most flexible and general route to the camptothecin class of molecules. The parallel synthesis of several libraries of silatecan and homosilatecan libraries is summarized. One of the first-generation silatecans, DB-67, is emerging as a serious candidate for cancer chemotherapy.
Similar articles
-
The combinatorial synthesis of racemic homosilatecan libraries via a cascade radical annulation.Ann N Y Acad Sci. 2000;922:317-9. doi: 10.1111/j.1749-6632.2000.tb07053.x. Ann N Y Acad Sci. 2000. PMID: 11193911 No abstract available.
-
Synthesis and pharmacology of new camptothecin drugs.Mini Rev Med Chem. 2005 May;5(5):425-39. doi: 10.2174/1389557053765547. Mini Rev Med Chem. 2005. PMID: 15892685 Review.
-
Synthesis and evaluation of a novel E-ring modified alpha-hydroxy keto ether analogue of camptothecin.Bioorg Med Chem. 2002 Jan;10(1):103-10. doi: 10.1016/s0968-0896(01)00252-8. Bioorg Med Chem. 2002. PMID: 11738612
-
Review camptothecin: current perspectives.Curr Med Chem. 2006;13(17):2021-39. doi: 10.2174/092986706777585004. Curr Med Chem. 2006. PMID: 16842195 Review.
-
Solution phase synthesis of libraries of polycyclic natural product analogues by cascade radical annulation: synthesis of a 64-member library of mappicine analogues and a 48-member library of mappicine ketone analogues.J Comb Chem. 2000 Nov-Dec;2(6):639-49. doi: 10.1021/cc000032i. J Comb Chem. 2000. PMID: 11126292
Cited by
-
A phase I study of 7-t-butyldimethylsilyl-10-hydroxycamptothecin in adult patients with refractory or metastatic solid malignancies.Clin Cancer Res. 2010 Jan 15;16(2):673-80. doi: 10.1158/1078-0432.CCR-09-2429. Epub 2010 Jan 12. Clin Cancer Res. 2010. PMID: 20068096 Free PMC article. Clinical Trial.
-
The effect of breast cancer resistance protein, multidrug resistant protein 1, and organic anion-transporting polypeptide 1B3 on the antitumor efficacy of the lipophilic camptothecin 7-t-butyldimethylsilyl-10-hydroxycamptothecin (AR-67) in vitro.Drug Metab Dispos. 2013 Jul;41(7):1404-13. doi: 10.1124/dmd.112.050021. Epub 2013 Apr 25. Drug Metab Dispos. 2013. PMID: 23620484 Free PMC article.
-
The Emerging Role of the SLCO1B3 Protein in Cancer Resistance.Protein Pept Lett. 2020;27(1):17-29. doi: 10.2174/0929866526666190926154248. Protein Pept Lett. 2020. PMID: 31556849 Free PMC article. Review.
-
Camptothecins: a review of their chemotherapeutic potential.Drugs. 2002;62(14):2039-57. doi: 10.2165/00003495-200262140-00004. Drugs. 2002. PMID: 12269849 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous